倾向性评分估计治疗启动决策效应:科学现状
本文综述倾向性评分(Propensity Score)在真实世界证据生成中的应用,聚焦单一治疗决策(两种治疗选择间)场景。阐述其与潜在结局框架的契合、研究设计含义、估计程序、实施选项和报告五方面,并讨论随时间变化的比较类型、实施方法和平衡评估技术及不断演进的应用。
要点
- 倾向性评分将多个已测混杂因素汇总为单一评分,减少已测混杂导致的偏倚。
- 倾向性评分分析需关注与潜在结局框架的对齐、研究设计、估计、实施和报告五方面。
- 比较类型、实施方法和平衡评估技术随时间变化,需结合场景选择。
核心结论
- 倾向性评分方法可减少已测混杂偏倚,用于非实验研究中的因果效应估计。
研究设计与样本
- 本文为综述,概述倾向性评分在真实世界证据生成中的应用,聚焦单一治疗决策场景。
主要发现
- 倾向性评分基于接受治疗的概率,汇总多个已测混杂因素的分布,以减轻治疗组与比较组间这些已测混杂因素分布的失衡。
- 倾向性评分方法由Rosenbaum和Rubin于1983年正式提出,此后在多个科学学科中应用日益增多。
临床怎么用
- 在非实验研究中,可利用倾向性评分减少已测混杂偏倚,获得偏倚更小的治疗效应估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Confounding can cause substantial bias in nonexperimental studies that aim to estimate causal effects. Propensity score methods allow researchers to reduce bias from measured confounding by summarizing the distributions of many measured confounders in a single score based on the probability of receiving treatment. This score can then be used to mitigate imbalances in the distributions of these measured confounders between those who received the treatment of interest and those in the comparator population, resulting in less biased treatment effect estimates. This methodology was formalized by Rosenbaum and Rubin in 1983 and, since then, has been used increasingly often across a wide variety of scientific disciplines. In this review article, we provide an overview of propensity scores in the context of real-world evidence generation with a focus on their use in the setting of single treatment decisions, that is, choosing between two therapeutic options. We describe five aspects of propensity score analysis: alignment with the potential outcomes framework, implications for study design, estimation procedures, implementation options, and reporting. We add context to these concepts by highlighting how the types of comparator used, the implementation method, and balance assessment techniques have changed over time. Finally, we discuss evolving applications of propensity scores.
引用
- Webster-Clark M, Stürmer T, Wang T, et al. Using propensity scores to estimate effects of treatment initiation decisions: State of the science. Stat Med. 2020. PMID: 33377193. doi:10.1002/sim.8866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。